Pages that link to "Q33690844"
Jump to navigation
Jump to search
The following pages link to A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders (Q33690844):
Displaying 50 items.
- Autism spectrum disorder in adults: diagnosis, management, and health services development (Q26741443) (← links)
- New Therapeutic Options for Autism Spectrum Disorder: Experimental Evidences (Q26771762) (← links)
- A review of rhythm and responsiveness of cortisol in individuals with autism spectrum disorders (Q26823076) (← links)
- Mental health services for individuals with high functioning autism spectrum disorder (Q26828583) (← links)
- Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders (Q33664787) (← links)
- A descriptive social and health profile of a community sample of adults and adolescents with Asperger syndrome (Q33744556) (← links)
- Rates and predictors of adherence to psychotropic medications in children with autism spectrum disorders. (Q34424843) (← links)
- Psychiatric comorbidity and medication use in adults with autism spectrum disorder. (Q34426226) (← links)
- Commentary on ‘Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)’ (Q35178499) (← links)
- High prescription drug use and associated costs among Medicaid-eligible children with autism spectrum disorders identified by a population-based surveillance network (Q35619221) (← links)
- Aberrant Behaviors and Co-occurring Conditions as Predictors of Psychotropic Polypharmacy among Children with Autism Spectrum Disorders (Q35641660) (← links)
- Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit/hyperactivity disorder. (Q35757716) (← links)
- Challenges in the diagnosis and treatment of depression in autism spectrum disorders across the lifespan (Q35899465) (← links)
- Is Medication Information for Children with Autism Spectrum Disorder Monitored and Coordinated Across Professionals? Findings from a Teacher Survey (Q36703079) (← links)
- Change in the Behavioral Phenotype of Adolescents and Adults with FXS: Role of the Family Environment (Q36784495) (← links)
- Trajectories of internalizing and externalizing symptoms among adults with autism spectrum disorders (Q36788588) (← links)
- Emergency Department Use Among Adults with Autism Spectrum Disorders (ASD). (Q36835688) (← links)
- Prevalence and Predictors of Psychotropic Use in Children with High-Functioning ASDs (Q36898576) (← links)
- Atypical lateralization of motor circuit functional connectivity in children with autism is associated with motor deficits (Q37096854) (← links)
- Prescription Drug Use and Polypharmacy Among Medicaid-Enrolled Adults with Autism: A Retrospective Cross-Sectional Analysis (Q37452761) (← links)
- Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care. (Q37598430) (← links)
- Planning Skills in Autism Spectrum Disorder Across the Lifespan: A Meta-analysis and Meta-regression (Q37709982) (← links)
- CD38 and its role in oxytocin secretion and social behavior. (Q37974001) (← links)
- A systematic review of psychosocial interventions for adults with autism spectrum disorders (Q38028879) (← links)
- Autism spectrum disorders: an overview on diagnosis and treatment (Q38154183) (← links)
- The use of antipsychotics in preschoolers: a veto or a sensible last option? (Q38180865) (← links)
- Brief Report: Understanding Crisis Behaviors in Hospitalized Psychiatric Patients with Autism Spectrum Disorder--Iceberg Assessment Interview (Q38577669) (← links)
- A Scoping Review of Health Disparities in Autism Spectrum Disorder (Q38649757) (← links)
- Mass spectrometric evaluation of neurotransmitter levels in IMR 32 cell line in response to Ayurvedic medicines (Q38769865) (← links)
- Physical Activity, Screen-Time Behavior, and Obesity Among 13-Year Olds in Ireland with and without Autism Spectrum Disorder (Q38817377) (← links)
- Aripiprazole for the treatment of irritability and aggression in children and adolescents affected by autism spectrum disorders. (Q38889269) (← links)
- Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review (Q38953538) (← links)
- Comorbidity prevalence, healthcare utilization, and expenditures of Medicaid enrolled adults with autism spectrum disorders (Q39163633) (← links)
- Use of Sleep Evaluations and Treatments in Children with Down Syndrome (Q39473601) (← links)
- Intellectual developmental disorder in adult psychiatry: A 24-year register study (Q39813042) (← links)
- Subregional differences in intrinsic amygdala hyperconnectivity and hypoconnectivity in autism spectrum disorder (Q40212963) (← links)
- Trajectories, Long-Term Outcomes and Family Experiences of 76 Adults with Autism Spectrum Disorder (Q40317970) (← links)
- Self and informant reports of mental health difficulties among adults with autism findings from a long-term follow-up study (Q40898873) (← links)
- Training of child and adolescent psychiatry fellows in autism and intellectual disability (Q40989148) (← links)
- Psychotropic Medication Use among Insured Children with Autism Spectrum Disorder (Q45298736) (← links)
- The missing link: delayed emotional development predicts challenging behavior in adults with intellectual disability (Q47288481) (← links)
- Medication use by adolescents and adults with fragile X syndrome. (Q47596691) (← links)
- Problems managed and medications prescribed during encounters with people with autism spectrum disorder in Australian general practice (Q47621260) (← links)
- Use and cost of psychotropic drugs among recipients with autism in a state Medicaid fee-for-service programme (Q47949661) (← links)
- Awareness and Knowledge of Autism Spectrum Disorders Among Pharmacists: A Cross-Sectional Study in Palestinian Pharmacy Practice (Q48506282) (← links)
- Psychotropic medication trends among children and adolescents with autism spectrum disorder in the Medicaid program. (Q50309513) (← links)
- Serotonin as a link between the gut-brain-microbiome axis in autism spectrum disorders. (Q52609941) (← links)
- Schema therapy as treatment for adults with autism spectrum disorder and comorbid personality disorder: Protocol of a multiple-baseline case series study testing cognitive-behavioral and experiential interventions. (Q55316611) (← links)
- Use of Psychotropic Drugs among Children and Adolescents with Autism Spectrum Disorders in Denmark: A Nationwide Drug Utilization Study (Q57478390) (← links)
- Psychotropic medication use in autism spectrum disorders may affect functional brain connectivity (Q57653167) (← links)